Is SONN stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
On Friday 21st of November 2014, Sonnet BioTherapeutics had a stock price of $150 550. If you invested back then, your return now would be a loss of $-150 547 per share or -100.00%
Yes, the average daily trading liquidity for Sonnet BioTherapeutics is $1.13 million. You should therefore be able to get in and out of your positions relatively fast.
Sonnet BioTherapeutics has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Sonnet BioTherapeutics to be medium [0.7 out of 1]